News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,754 Results
Type
Article (8019)
Company Profile (140)
Press Release (476594)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166766)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9763)
Job Trends (8576)
News (238254)
Policy (17923)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33155)
ALS (105)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (264)
Approvals (10380)
Artificial intelligence (321)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3652)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47874)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (751)
Cystic fibrosis (85)
Data (5661)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4187)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73717)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87637)
Executive appointments (701)
FDA (12400)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9318)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8674)
Medtech (8819)
Mergers & acquisitions (14384)
Metabolic disorders (709)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1826)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (508)
Peanut (31)
People (41243)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15469)
Phase 2 (21381)
Phase 3 (14400)
Pipeline (7344)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3020)
Recruiting (6)
Regulatory (14831)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (323)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (46)
Last 7 days (213)
Last 30 days (1581)
Last 365 days (19040)
2026 (12341)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34603)
2021 (37179)
2020 (33472)
2019 (23264)
2018 (17477)
2017 (18768)
2016 (17926)
2015 (24264)
2014 (21679)
2013 (18135)
2012 (20223)
2011 (20442)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17902)
Australia (2130)
California (11989)
Canada (3148)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24639)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (701)
India (51)
Indiana (314)
Iowa (15)
Japan (403)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7861)
Michigan (308)
Minnesota (560)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2822)
North Carolina (1280)
North Dakota (4)
Northern California (6003)
Ohio (278)
Oklahoma (14)
Oregon (18)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4983)
Tennessee (120)
Texas (1942)
United States (38906)
Utah (360)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (929)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,754 Results for "impedimed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
ImpediMed to Present Chronic Breast Cancer-related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting
ImpediMed announced today that it will present new results from a breast cancer-related lymphedema study during a poster session at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Orlando, FL on Friday, April 12, 2024.
April 11, 2024
·
5 min read
Biotech Bay
ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
ImpediMed Limited is pleased to announce the signing of a Global Strategic Commercial Partnership and pilot program with GenesisCare.
October 4, 2022
·
4 min read
Biotech Beach
ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer
ImpediMed Limited is pleased to announce the recent expansion of the use of its SOZO® Digital Health Platform at leading cancer centers dedicated to reducing the impact of lymphedema on breast cancer patients.
October 11, 2022
·
3 min read
Job Trends
ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease
ImpediMed Limited (ASX: IPD) today announced the details of the third contract extension related to the use of its SOZO® Digital Health Platform in a clinical trial being conducted for AstraZeneca.
November 16, 2022
·
2 min read
Biotech Beach
New Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022
ImpediMed Limited (ASX: IPD) is pleased to announce that two abstracts evaluating use of ImpediMed’s SOZO® Digital Health Platform in heart failure patients were accepted for poster presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022 taking place from September 30 to October 3 in Washington D.C.
July 15, 2022
·
3 min read
Biotech Beach
ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
ImpediMed Limited today announced two poster presentations at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, which is taking place Sept. 30 to Oct. 3 in Washington D.C.
September 30, 2022
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Biotech Beach
New Data Evaluating ImpediMed’s SOZO® Digital Health Platform to Assess Bone in Cancer Patients to be Presented at 39th Annual Miami Breast Cancer Conference
ImpediMed Limited (ASX.IPD), is pleased to announce an abstract comparing concurrent measures using ImpediMed’s SOZO® Digital Health Platform and dual x-ray absorptiometry (DXA) for assessing bone mineral content in cancer patients was accepted for poster presentation at the 39th Annual Miami Breast Cancer Conference.
February 15, 2022
·
3 min read
Biotech Beach
New Bone Data Showing Strong Correlation between ImpediMed’s SOZO and DXA in Cancer Patients Presented at 39th Annual Miami Breast Cancer Conference
ImpediMed Limited (ASX.IPD), a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health is pleased to announce a poster showing strong correlation between ImpediMed’s SOZO® Digital Health Platform and dual x-ray absorptiometry (DXA) for assessing bone mineral content in cancer patients was presented at the 39th Annual Miami Breast Cancer Conference.
March 7, 2022
·
4 min read
Biotech Beach
ImpediMed Announces Next Generation of SOZO® Digital Health Platform Software
ImpediMed Limited, a global medical technology company using bioimpedance spectroscopy to generate powerful data to improve patient health, announced the release of the next generation software for the SOZO® Digital Health Platform.
June 7, 2021
·
5 min read
1 of 48,476
Next
